For people living with autoimmune conditions, the disease burden remains high. We’re eager to share how our targeted solutions are addressing unmet autoimmune patient needs at the European Academy of Neurology Congress. Discover more about our commitment to this community: bit.ly/4eBL0Tu #TogetherWeDiscover #EAN2024
argenx’s Post
More Relevant Posts
-
Can't we increase not find a solid state electrolyte that would act as a reducer for depolarization of cell membrane like the new lithium batteries? I don't really know anything about science, but I like to imagine possibilities. 😀 #houseoflovingawareness #coloradomentalwellnessinitiative #willojontv #neurology #science #mentalhealth #mentalhealthmatters #mentalwellness #americanspiritsthemovie
This week, we are attending the American Epilepsy Society 2023 annual meeting, where we are excited to sponsor a satellite symposium session alongside Practical Neurology. The fireside chat will cover what information is needed to optimize the referral process for rare forms of #epilepsy such as Dravet syndrome, Lennox-Gastaut syndrome and tuberous sclerosis complex, enable shorter times to accurate diagnosis, and improve patient outcomes. Register now to attend the session on December 1st at 6 PM ET: https://bit.ly/3GmMUYq #AES2023
-
-
I am proud of the Phase 3 data #MyCompany, Johnson & Johnson Innovative Medicine presented at the 2024 European Academy of Neurology Meeting. For patients with generalized myasthenia gravis (gMG), a chronic, rare autoantibody-driven disease, more effective treatment options are crucial for improving quality of life. My colleagues and I are driven to address the remaining unmet needs in this space, and we are grateful to have collaborated with other industry experts who share this passion for purposeful scientific exploration at #EAN2024. #JNJNeuroscience #JNJImmunology
-
Global Therapeutic Area Head, Neuroscience at Johnson & Johnson Innovative Medicine
Results from our Phase 2 Vivacity-MG study evaluating nipocalimab in adults with moderate-to-severe generalized myasthenia gravis were published in Neurology by the American Academy of Neurology. These results reinforce our path to progress in offering safer, more effective and tolerable treatment options to people living with this rare autoantibody disease of the nervous system. I want to extend my gratitude to our dedicated research team and to our clinical trial participants, without whom we could not advance the science towards better therapeutics. Access the article here: https://bit.ly/3NCoRZp #MyCompany #MyastheniaGravis
-
-
February 29 is #RareDiseaseDay. Learn more about rare diseases in neurology through CNSA's Clinical Proceedings series ▶️ https://bit.ly/3a2xoEh
-
-
🧠✨ Dive into the fascinating world of neurology at the Global Neurology Summit 2024! 🌍🔬 This eMedEvents blog uncovers the details of this hybrid event focusing on innovative therapies for neurological disorders - https://bit.ly/43CEGWI 🏥📝This conference, organized by eMedEd, promises to be a transformative experience, bringing together neurologic experts from around the globe to collaborate and advance patient care. #NeurologyConference #GlobalSummit #MedicalEducation #emedevents #cmeconferences #medicalconferences #eMedEvents
-
-
Next webinar 11.01.2024, Dr. Maxwell Damian: Respiratory insufficiency in Neuromuscular Diseases #EURONMD ERN-RND, European Reference Network for Rare Neurological Diseases European Academy of Neurology #EANeurology #webinars #neuromuscular #RareMuscleDiseases
➡️ In partnership with ERN-RND, European Reference Network for Rare Neurological Diseases & European Academy of Neurology, we are running a series of webinars every Thursday in January. This month’s topic is #RareMuscleDiseases 💪 💬 Each webinar will last approximately 1 hour with an opportunity for viewers to ask questions about the topic. Sign up and learn virtually from experts in neuromuscular diseases! 👉👉 https://lnkd.in/gnbVTmQ3
-
-
Don’t miss our October 4th Autoimmunity Speaker series event with Lisa Christopher-Stine, M.D., M.P.H., Director of the Johns Hopkins Myositis Center and Professor of Medicine and Neurology. The webinar will focus on “The Role of Anti-HMGCR Autoantibodies in Myositis” and qualifies for PACE credit. Tomorrow’s session will: - Define the important role of autoantibodies in idiopathic inflammatory myopathies (myositis) - Enumerate the salient histologic and clinical features of anti-HMGCR myopathy - Examine the role of HMGCR autoantibodies in myositis Register today (and we’ll see you tomorrow)! https://hubs.ly/Q022f1B50 #Autoimmunity #Autoantibodies #Myositis #HMGCR #PACECredit
-
-
Stop by Booth #752 at the 2024 American Academy of Neurology (AAN) Annual Meeting. Learn more about the Cognivue Clarity assessment which offers an advanced approach to brain performance measurement that is robust, validated, flexible, and personalized. Don’t miss our poster presentation on April 15th! Presentation number 008 in neighborhood 9 from 5:30-6:30pm. Poster titled: Cognivue Clarity in the Detection of Biomarker Confirmed Mild Cognitive Impairment and Alzheimer's Disease. #AANAM #cognitivehealth #earlydetection #brainhealth #mildcognitiveimpairment #cognition #alzheimersdisease #cognivue
-
Chief Executive Officer at USA and International Research Inc.
3wLooking forward to learning more about your innovative solutions at EAN 2024! #TogetherWeDiscover #EAN2024